GB202102063D0
|
|
HDR Enhancers
|
GB202101568D0
|
|
System
|
GB202101508D0
|
|
Process for making adenoassociated viral vectors
|
GB202101107D0
|
|
Method of genome editing
|
GB202019908D0
|
|
Cripr polypeptides
|
GB202013058D0
|
|
Process for making a recombinant AAV library
|
GB202013057D0
|
|
Method of making recombinant aavs
|
GB202013060D0
|
|
Cell line
|
GB202011437D0
|
|
Process for making adenoassociated viral vectors
|
GB202010835D0
|
|
Process for making adenoassociated viral vectors
|
GB202009241D0
|
|
Process for making adenoassociated virel vectors
|
GB202007577D0
|
|
Hdr enhancers
|
WO2020183133A1
|
|
Method of selecting for antibodies
|
GB202001486D0
|
|
Process for making adenoassociated viral vectors
|
GB202001484D0
|
|
DNA amplification method
|
GB201914819D0
|
|
Method of selecting for antibodies
|
GB201913333D0
|
|
Method of selecting for antibodies
|
GB201903270D0
|
|
Method of selecting for antibodies
|
GB201903233D0
|
|
Method of selecting for antibodies
|
GB201901571D0
|
|
Inducible AAV sysyem
|